Stockhub

Catalent, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 August 2022

  • curprev 11:1811:18, 29 August 2022 >Nick 1,940 bytes +1,940 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services fo..."
Retrieved from "https://stockhub.co/research/Catalent,_Inc."